SCHEMBL4960948

SCHEMBL4960948

CCc1nc2ccccc2c(=O)n1-c1ccc(NC(=O)O)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.62
LMNA P02545 2/20 0.62
TP53 P04637 2/20 0.61
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
BLM P54132 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
MAPT P10636 2/20 0.57
PDE10A Q9Y233 4/20 0.57
ALDH1A1 P00352 3/20 0.56
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
KCNH2 Q12809 1/20 0.54
HRH3 Q9Y5N1 1/20 0.54
NPC1 O15118 1/20 0.54
RAB9A P51151 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4955792 0.93 MEN1 (0.69) MAPK1LMNATP53MEN1KMT2A
SCHEMBL4957073 0.92 LMNA (0.77) MAPK1LMNATP53MEN1KMT2A
SCHEMBL4467032 0.87 MAPK1 (0.76) MAPK1LMNAMEN1KMT2ABLM
SCHEMBL8242227 0.86 NPC1 (0.70) MAPK1LMNAMEN1KMT2ABLM
SCHEMBL4956958 0.84 LMNA (0.72) MAPK1LMNATP53MEN1KMT2A
SCHEMBL4957618 0.83 MAPK1 (0.60) MAPK1LMNAMEN1KMT2ABLM
SCHEMBL1484129 0.83 MEN1 (0.66) MAPK1LMNAMEN1KMT2ABLM
SCHEMBL8649618 0.82 MAPK1 (0.67) MAPK1LMNAMEN1KMT2ABLM
SCHEMBL4955797 0.82 LMNA (0.72) MAPK1LMNAMEN1KMT2ABLM
SCHEMBL14115046 0.80 LMNA (0.66) MAPK1LMNATP53MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO disclosed